Top CRISPR Companies in 2025

The global CRISPR market is projected to increase from USD 3.21 billion in 2025 to USD 5.47 billion by 2030, registering a robust CAGR of 11.2% during the forecast period. The market is highly competitive, with several major players striving to expand their market presence. Prominent companies operating in the CRISPR market include Thermo Fisher Scientific Inc. (US), Agilent Technologies Inc. (US), Merck KGaA (Germany), and GenScript (US), among others. These leading players are pursuing a range of growth strategies—both organic and inorganic—such as partnerships, agreements, expansions, and acquisitions, to strengthen their market position and drive innovation in CRISPR technologies.

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134401204

Thermo Fisher Scientific, Inc. (US) is one of the leading players in the CRISPR market. The company has a presence in more than 60 countries and offers a diversified product portfolio of reagents, enzymes, kits, and services in the CRISPR market. The company has a strong geographical presence in Europe, North America, and the Asia Pacific. Thermo Fisher Scientific mainly focuses on providing products and services for CRISPR. The company focuses on R&D investments to strengthen its global presence. For instance, in 2024, the company invested USD 1.4 billion to deliver exciting new technologies across its businesses, helping its customers break new ground in their important work.

Agilent Technologies, Inc. (US) is one of the dominant players in the CRISPR market. The company has a global presence in more than 30 countries and has diversified products for the CRISPR market. The company’s product offerings include reagents, enzymes, and services such as the SureGuide Cas9 Nuclease Kits, SureGuide gRNA Control Kits, etc. Its robust portfolio enables the company to increase collaboration with clients, from early phenotypic screening to lead optimization. The company’s leading position can be attributed to its strong brand recognition in this market.

Merck KgaA (Germany) provides health science solutions that focus on technologies and services ranging from discovery and development to diagnosis. In the Life Sciences segment, Merck offers a variety of products and services, including gene editing and CRISPR tools, to support research in cell, gene, and protein studies. The company's strong portfolio enhances collaboration with clients, and its leading position in the market is due to its strong brand recognition.

Market Ranking

The CRISPR market is highly competitive, with four major players collectively holding 25-27% of the total market share. Thermo Fisher Scientific offers a diverse range of products and services within the CRISPR sector. Agilent Technologies has established a significant market presence by specializing in specific enzymes and libraries for CRISPR applications. Merck has strengthened its position by providing a variety of products and services in the life sciences segment, including those for gene editing and CRISPR technology, to support research in cell, gene, and protein studies. As the demand for CRISPR technology continues to grow, current suppliers are enhancing their offerings to address the evolving needs across various applications.

The remaining 73–75% of the market is occupied by various regional and emerging vendors, which presents opportunities for smaller companies to establish a presence. Market competition is influenced by several key factors, including the growing demand for personalized medicines, an increase in spending on innovative research, and strategic collaborations among established players in the industry.